The NRF2 activator DH404 attenuates adverse ventricular remodeling post-myocardial infarction by modifying redox signalling.
Bubb KJ, Kok C, Tang O, Rasko NB, Birgisdottir AB, Hansen T, Ritchie R, Bhindi R, Reisman SA, Meyer C, Ward K, Karimi Galougahi K, Figtree GA.
Bubb KJ, et al. Among authors: karimi galougahi k.
Free Radic Biol Med. 2017 Jul;108:585-594. doi: 10.1016/j.freeradbiomed.2017.04.027. Epub 2017 Apr 21.
Free Radic Biol Med. 2017.
PMID: 28438659